ADHD Medication Shortage 2026: What Long Island Families Should Know
By Benjamin Zohar, NCACIP
Professional Member: NAADAC, NAMI, CCAPP, AAPNY
Contributor: ISSUP – International Society of Substance Use Professionals
Introduction
The ADHD medication shortage continuing into 2026 has significantly affected families across Long Island. Pharmacies in Nassau and Suffolk counties are reporting inconsistent access to [Adderall](/addiction/adderall-addiction), methylphenidate products, and other stimulant medications. This shortage is part of a larger national and global supply disruption.
Two recent ISSUP articles provide important insight into the broader public-health and regulatory factors behind this shortage:
These ISSUP publications outline the clinical, regulatory, and prevention implications of the ongoing stimulant shortage and help contextualize what families are experiencing locally.
Why the ADHD Medication Shortage Continues in 2026
Several authoritative sources confirm that ADHD stimulant medications remain in shortage.
ASHP Shortage Data
The American Society of Health-System Pharmacists reports that multiple amphetamine formulations are still "currently in shortage":
DEA Quotas (2024–2025)
The DEA regulates stimulant production through Aggregate Production Quotas (APQs). These limits were updated for 2024–2025 but still fall short of national demand:
Prescribing & Dispensing Trends
A peer-reviewed 2025 Pediatrics study documented measurable declines in amphetamine dispensing and shifts toward alternative medications:
What Long Island Families Can Do Right Now
1. Contact Prescribers Early
Do not wait until you run out of medication. Many Long Island psychiatrists and pediatricians are adjusting refill protocols and may recommend:
- Temporary alternative medications
- Different dosages or formulations
- Non-stimulant treatment options
Reference: NIMH ADHD Treatment Overview
2. Call Multiple Pharmacies
Pharmacy availability varies widely across Long Island. Families should call:
- Large retail chains
- Independent pharmacies
- Mail-order pharmacies
- Hospital or medical-center pharmacies
Reference: FDA Drug Shortage Database
3. Avoid Unregulated or Counterfeit Sources
The CDC warns of counterfeit "Adderall" tablets containing fentanyl, methamphetamine, or other dangerous substances. If you suspect someone has taken a counterfeit pill, medication-assisted treatment providers can help assess the situation.
Reference: CDC Health Alert: Counterfeit Prescription Pills Containing Fentanyl
Families should never seek medication from social media, peer sources, or non-verified online pharmacies. Learn more about Certified Recovery Peer Advocates.
4. Use Behavioral Supports During Medication Gaps
Recommendations aligned with ISSUP prevention guidance include:
- Consistent daily structure
- Use of timers and task sequencing
- Frequent movement breaks
- Body-doubling for homework/work tasks
- Environmental modifications to reduce distraction
These strategies help families manage symptoms until medication access stabilizes.
How ISSUP Guidance Supports Local Action
The ISSUP articles referenced above emphasize:
- Community-level prevention strategies
- Communication frameworks for families
- Risk mitigation during medication shortages
- Awareness around counterfeit medication risks
- The importance of coordinated support systems during access disruptions
These insights apply directly to Long Island communities where shortages affect families, schools, clinicians, and behavioral-health programs.
Conclusion
The ADHD medication shortage is expected to continue through 2025, but families on Long Island can reduce disruption by planning ahead, staying connected with prescribers, using pharmacy alternatives responsibly, and avoiding unsafe sources. High-authority medical guidance combined with ISSUP's prevention resources provides a reliable framework during this unpredictable period.
LongIsland.rehab will continue monitoring updates from DEA, FDA, ASHP, CDC, and ISSUP to support the community through this ongoing challenge.
About the Author
Benjamin Zohar, NCACIP
Nationally Certified Advanced Addiction Intervention Professional
Professional Member: NAADAC, NAMI, CCAPP, AAPNY
Contributor: ISSUP Knowledge Share
Founder: InterventionNY
